Home
Search
Tell a Colleague
About
Contact
Developmental Disabilities Grants
Subscribe to Developmental Disabilities Grants by
Email:
or
RSS:
Medical Research Grants and Postdoctoral Fellowships Offered for Studies Aimed at Treatment of Fragile X
Grantor:
FRAXA Research Foundation
Region:
All Regions
Closes:
02/01/2009
Maximum:
$60,000
Medical Research Grants and Postdoctoral Fellowships Offered for Studies Aimed at Treatment of Fragile X
INTRODUCTION
The FRAXA Research Foundation offers a grants and fellowships program designed to encourage research aimed at finding a specific treatment for fragile X syndrome.
Fellowships of up to $40,000 per year will be offered to support postdoctoral fellows who want to pursue research in fragile X (salary plus fringe benefits and/or travel to meetings).
FRAXA also invites investigator-initiated research applications for innovative pilot studies aimed at developing and characterizing new therapeutic approaches for the treatment and ultimate cure of fragile X syndrome. There is no funding limit to this category of grant, but typical funding levels are $30K - 60K.
FRAXA is particularly interested in preclinical studies of potential pharmaceutical and genetic treatments and studies aimed at understanding the function of the FMR1 gene. New applications are accepted each year on February 1. If February 1 falls on a Saturday or Sunday, the deadline will be the following Monday.
Fellowships and grants are generally awarded for a period of one year. Based on reasonable progress during that year, awards may be renewable for a second year. Renewal applications are due on February 1, at least three months before the second year of funding is needed. If February 1 falls on a Saturday or Sunday, the deadline will be the following Monday.
PURPOSE OF GRANTS/FELLOWSHIPS
The purpose of this grant program is to promote research aimed at finding a specific treatment for fragile X syndrome. FRAXA's goal is to bring practical treatment into current medical practice as quickly as possible; therefore, preference will be given to research projects that have a clear practical application and the results of which will be shared with other qualified researchers in a timely fashion.
ELIGIBILITY FOR GRANTS/FELLOWSHIPS
Institutions receiving grants must be recognized as nonprofit. In the US, this means that institutions are exempt from federal income taxes. Preference is given to institutions within the United States.
Individuals nominated by applicant institutions for the postdoctoral fellowship should have training and experience at least equal to the Ph.D. or M.D. Level. Preference is given to United States citizens.
ACCEPTABLE COSTS
Acceptible costs covered by FRAXA postdoctoral fellowships and investigator-initiated awards are limited to:
Postdoctoral salary
Fringe benefits
A budget for consumable supplies
FRAXA reserves the right to cover any item if explicitly authorized by FRAXA's Board of Directors. However, FRAXA is unable to pay for indirect costs under any circumstances.
Fellowships and grants are awarded for the period of one year and may be renewed for a second year, based on satisfactory progress. A financial report and progress report are required at the end of each year.
AMENDMENT OF POLICIES
The FRAXA Research Foundation reserves the right to modify its policies governing grants at any time. The grantee agrees to abide by any changes or to terminate the grant at the time when such changes become effective. Failure to abide by the policies governing grants shall be considered sufficient grounds for cancellation of a grant or refusal to consider any pending application by the grantee.
PROHIBITION OF DISCRIMINATION
No person shall be excluded from participation in or denied the benefits of any program or activity receiving financial assistance from FRAXA because of race, ethnic origin, religion, sex, or sexual orientation.
HUMAN AND ANIMAL SUBJECTS
Human subjects studied in the course of research conducted under a grant are under no circumstances a responsibility of FRAXA. Human subjects in a program supported by FRAXA shall be volunteers in any survey, study or procedure. Research involving human subjects must have Institutional Review Board approval.
If animals are used in the proposed study, written certification must be provided to FRAXA indicating that proper treatment, care, and humane conditions have been provided. Research involving animal subjects must have Institutional Animal Care and Use Committee approval.
OBLIGATIONS OF THE GRANTEE
In accepting a grant, the applying institution undertakes that at its conclusion it will
Submit promptly to FRAXA a complete final report on the work pursued.
On awards of more than one year duration, a yearly report will be expected.
Supply an accounting of funds received from FRAXA and expenditures made in such detail and in such manner as may meet Internal Revenue Service procedures.
Recognize the support of FRAXA in any published article resulting from the work pursued with a credit line reading "Supported in part by a grant from the FRAXA Research Foundation"
Recognize the support of FRAXA in any presentation of the at professional meetings and conferences.
PUBLICATION AND DISSEMINATION OF RESULTS
FRAXA's purpose in providing grants is to speed up progress towards treatment for fragile X. Therefore, in accepting an award, the Principal Investigator undertakes to publish the results of the work pursued in the primary literature, in a timely fashion. Once published, the reagents, methods, materials, and products of the work must be made available to other qualified researchers. FRAXA reserves the right to share in any proceeds from an invention or discovery developed under this grant, including licensing fees and patent rights.
PUBLICITY ON WORK UNDER GRANT
The grantee institution and Principal Investigator will cooperate fully with FRAXA in announcement through the news media of grants awarded and in materials prepared to publicize work under the grant. FRAXA will publish periodic descriptions and updates on funded projects in its quarterly members' newsletter.
APPLICATION PROCESS
Potential applicants are encouraged to submit a brief letter of inquiry describing the proposed project before writing a full application. No specific application format is required, but an NIH R01 proposal is acceptable.
Please provide the following information with your application:
Description of the proposed project (6-12 pages recommended)
Curriculum Vitae for the Principal Investigator
Curriculum Vitae for the Postdoctoral Fellow to be supported under the grant
Names of 3 references who are willing to be contacted to provide recommendations for candidate postdoctoral fellow (not necessary for principal investigators)
Financial accounting of how the funds will be spent, with dollar distribution into major component items
A full accounting of any other current and submitted sources of support for this project and other lab research
Requested start date of the project. The earliest possible start date is 3 months after receipt of the application; applicants will be notified of awards in 2 months.
Send one complete copy of the application by email to fraxa@comcast.net, as an attached file in Acrobat PDF format. Alternately, this electronic copy may be sent to the address below on a CD. Also please send one copy of the application to:
Michael Tranfaglia, MD
Medical Director
FRAXA Research Foundation
45 Pleasant St. Second Floor
Newburyport, MA 01950
Applications must be postmarked by the deadline date.
RENEWALS
FRAXA grants are awarded for a single year and are generally renewable, based on good progress being made the first year. We require a renewal application be submitted by FRAXA's regular deadline (February 1). The renewal application should consist of a detailed progress report for the first year and work plan for the second year, as well as a financial report of how first year funds were spent.
For further information contact Michael Tranfaglia at FRAXA
Phone (978) 462-1866
Fax: (978) 463-9985
Link:
http://www.fraxa.org/research_applicationGuidelines.aspx#application
Categories:
Attention Disorders
,
Autism
,
Developmental Disabilities
,
Learning Disabilities
,
Inheritable Disorders
,
Drug Discovery/ Drug Development
,
Genetics
,
Genomics
,
Novel Therapies
,
Pharmacology
,
Disease-Specific Research
Audience:
Geneticist , Physician Researcher, Scientist
Send this grant to a colleague
or bookmark / cite this grant:
Robert Guthrie PKU Scholarship
Grantor:
National PKU News
Region:
All Regions
Closes:
11/01/2008
Maximum:
$0
The Robert Guthrie PKU Scholarship
In memory of Dr. Robert Guthrie, this higher education scholarship program was started after his death in June 1995 by National PKU News. Dr. Guthrie developed the newborn screening test for phenylketonuria (PKU) in 1961. He then worked tirelessly for more than thirty years to establish newborn screening programs in the United States and many other countries. Every family of a child with PKU born after the mid-1960's, in a country where newborn screening is done, has reaped the benefits: more than 20,000 children have been saved from devastating mental retardation caused by untreated PKU. Early screening and a special diet have allowed these young people to grow up normally and lead full, productive lives.
There is no question that young people with PKU who are bound for higher education programs owe this opportunity to early screening and diet treatment. Without PKU identification early in life, they could be living in institutions or group homes for the retarded instead of planning to attend college or technical school. It seemed fitting to establish a scholarship program in Dr. Guthrie's name. The scholarship will benefit bright young people with PKU who are planning to obtain higher education degrees through college or technical school.
From its start in 1989, Dr. Guthrie was a member of the Board of Directors of National PKU News. National PKU News is a nonprofit organization devoted to bringing news and other information to families living with PKU. Beyond his single-minded dedication to preventing the mental retardation caused by PKU, throughout his life Dr. Guthrie was a devoted advocate for families living with it. National PKU News was started with his strong support and encouragement.
We hope families, and others whose lives have been touched by Dr. Guthrie's remarkable career, will generously support The Robert Guthrie PKU Scholarship.
Who is eligible:
Scholarships are open to any college-age young person with PKU who is on the diet. Residents of any country are eligible to apply.
Applicants must be accepted to an accredited college or technical school before the scholarship is awarded, but may apply for the scholarship before acceptance is confirmed.
Who will review scholarship applications:
A scholarship committee will review all applications. The committee consists of well-known PKU professionals and Guthrie family members.
Scholarship awards:
Each year, scholarships will be announced in January. The number of scholarships awarded each year and the amount granted may vary, depending on available funds.
Academic excellence and financial need of the applicant will be among factors considered.
Application deadline:
Applications will be available after August 1 each year for that year's applications.
Completed applications must be received by November 1 each year.
The Robert Guthrie PKU Scholarship
c/o National PKU News
6869 Woodlawn Ave. NE #116
Seattle, WA 98115-5469
Link:
http://www.pkunews.org/guthrie/guthschol.htm
Categories:
Birth Defects
,
Developmental Disabilities
,
Disability Issues
,
Scholarships
Audience:
High School Teacher, Student, Undergraduate, School Nurse, Parent, Patient
Send this grant to a colleague
or bookmark / cite this grant:
1
Choose a category:
All Categories
Academia
Academic Medicine
Acute Care
Aging
Alcoholism
Allergy Medicine
Alzheimer’s Disease
Amyotrophic Lateral Sclerosis
Anatomical Sciences
Anatomy
Anesthesiology
Animal Models
Animal Testing
Anxiety Disorders
Aplastic Anemia
Applied Research
Art Therapy
Arthritis
Arthroscopy
Assistive Technology
Asthma
Ataxia
At-Risk Populations
Attention Disorders
Audiology
Autism
Autoimmune Disorders
Basic Science
Behavioral Research
Biochemistry
Bioengineering
Bioethics
Bioinformatics
Biology
Biomarkers
Biomechanics
Biomedical Engineering
Biomedical Informatics
Biophysics
Biostatistics
Biotechnology
Bioterrorism
Bipolar Disorder
Birth Defects
Bleeding Disorders
Blindness
Blood
Blood Disorders
Bone
Brain
Brain Disorders
Brain Tumors
Breast Cancer
Burns
Cancer
Cancer Control
Cancer Immunology
Cancer Prevention
Cardiology
Cardiomyopathy
Cardiopulmonary Medicine
Cardiothoracic Surgery
Cardiovascular
Cardiovascular Surgery
Career Development
Cerebral Palsy
Cerebrovascular Disease
Cervical Cancer
Chemical Engineering
Chemical Sciences
Chemistry
Child Abuse
Child Nutrition
Child Psychiatry
Child Psychology
Chronic Kidney Disease
Chronic Obstructive Pulmonary Disease
Clinical Chemistry
Clinical Outcomes
Clinical Pathology
Clinical Pharmacy
Clinical Psychology
Clinical Research
Clinical Trials
Colon and Rectal Surgery
Communication Sciences and Disorders
Community Outreach
Community Pharmacy Practice
Community Service Programs
Complementary/Alternative Medicine
Complex Regional Pain Syndrome
Computer Modeling
Congenital Heart Disease
Continuing Education
Continuing Medical Education
Contraception
Corporate Science
Critical Care
Critical Care Nursing
Crohn’s Disease or Ulcerative Colitis
Cystic Fibrosis
Cytopathology
Deafness/Hearing Impairments
Dementia
Dental Education
Dental Health
Dental Schools
Dentistry
Depression
Dermatologic Surgery
Dermatology
Developmental Disabilities
Diabetes
Diabetes Education
Dialysis
Digestive Diseases
Disability Issues
Disability Research
Disaster Management
Disease-Specific Research
Distinguished Service
Diversity/Underrepresented Minorities
Domestic Violence
Dosimetry
Drug Discovery/ Drug Development
Drug Metabolism
Dyslipidemia
Dysphonia
Embryology
Emergency Medicine
Endocrinology
Endodontics
End-of-Life Care
Environmental Health
Environmental Sciences
Epidemiological Studies
Epilepsy
Essay Award
Ethics
Etiology
Evidence-Based Medicine
Eye
Family Caregiving
Family Medicine
Family Planning
Fellowships
Foot and Ankle Surgery
Forensic Sciences
Gastroenterology
Gastrointestinal Disorders
Gay and Lesbian Issues
Gene Therapy
General Surgery
Genetics
Genomics
Geriatric Pharmacy
Geriatrics
Gerontology
Glaucoma
Global Health
Glycobiology
Government
Hand Surgery
Hand Therapy
Headache
Health Care Access
Health Care Administration
Health Care Financing
Health Care Innovations
Health Disparities
Health Economics
Health Information Management
Health Insurance
Health Literacy
Health Policy
Health Promotion
Health Services
Health Services Research
Health Technology
Hearing and Speech
Heart Disease
Heart Failure
Hematology
Hemophilia
Hepatology
Histology
History of Medicine
History of Nursing
History of Science
Histotechnology
HIV/AIDS
Holistic Medicine
Home Health
Horticultural Therapy
Hospice
Hospitals
Human Genetics
Human Reproduction
Huntington’s Disease
Hypertension
Imaging
Immunization
Immunology
Industrial Laboratories
Infants
Infection Control
Infectious Diseases
Inflammatory Bowel Disease
Informatics
Inheritable Disorders
Innovation
Integrative Medicine
Internal Medicine
International Exchange
Interstitial Cystitis
Investigational New Drugs
Juvenile Diabetes
Kidney
Laboratory-Based Sciences
Laser Medicine
Law
Learning Disabilities
Leukemia
Life Sciences
Liver
Long Term Care/Nursing Homes
Lou Gehrig’s Disease
Lung
Lung Cancer
Lung Disease
Lung Transplantation
Lupus
Lymphatic Disease
Lymphoma
Malaria
Massage Therapy
Materials Chemistry
Maternal/Child Health
Maternal-Fetal Medicine
Medical Education
Medical Ethics
Medical Faculty
Medical Journalism
Medical Laboratory
Medical Libraries
Medical Marijuana
Medical Physics
Medical Schools
Medical-Surgical Nursing
Medication Administration
Medication/Treatment Adherence
Medicinal Chemistry
Melanoma
Menopause
Mental Health
Mentorship
Mesothelioma
Metabolics
Microbiology
Molecular Genetics
Molecular/Cellular Biology
Mood Disorders
Motor Disorders
Motor Neuron Diseases
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Muscle Disorders
Muscular Dystrophy
Musculoskeletal Conditions
Myasthenia Gravis
Myopathies
Nanotechnology
Neonatology
Nephrology
Nephrology Nursing
Neuroanatomy
Neurobiology
Neurochemistry
Neurodegenerative
Neuro-Imaging
Neuroimmunology
Neurology
Neuromuscular
Neuropathology
Neuropathy
Neuropharmacology
Neurophysiology
Neuropsychiatry
Neuropsychology
Neuropsychopharmacology
Neuroradiology
Neuroscience
Neurosurgery
Nonprofits
Novel Therapies
Nuclear Medicine
Nursing
Nursing Education
Nursing Ethics
Nursing Management
Nursing Research
Nursing Schools
Nutrition
Obesity
Obstetrics and Gynecology
Occupational Health
Occupational Therapy
Oncology
Oncology Nursing
Ophthalmology/Vision Science
Optometry
Oral and Maxillofacial Radiology
Oral Health
Organ and Tissue Donation
Organic Chemistry
Orthopedic Surgery
Orthopedics
Orthotics
Osteopathy
Osteoporosis
Otolaryngology
Otology
Ovarian Cancer
Pain Management
Palliative Care
Pancreas
Parenteral and Enteral Nutrition
Parkinson Disease
Pathogenesis
Pathology
Pathophysiology
Patient Education
Patient Safety
Pediatric Cardiology
Pediatric Hematology/Oncology
Pediatric Psychology
Pediatric Radiology
Pediatrics
PeriAnesthesia Nursing
Periodontology
Perioperative Nursing
Peripheral Nerve Disorders
Personality Disorders
Pharmaceutics/Drug Delivery
Pharmacoeconomics
Pharmacogenomics
Pharmacokinetics
Pharmacology
Pharmacotherapy
Pharmacy Education
Pharmacy Practice
Phlebotomy
Physical Chemistry
Physical Fitness/Sports
Physical Medicine
Physical Rehabilitation
Physical Therapy
Physiology
Pilot Studies
Pituitary Disorders
Plastic and Reconstructive Surgery
Podiatric Medicine
Pregnancy
Preventive Medicine
Primary Care
Probiotics
Prostate Cancer
Psoriasis
Psychiatry
Psychology
Psychosocial
Psychotherapy
Public Health
Public Outreach and Science Education
Public Policy
Public Safety
Public Service
Pulmonary Medicine
Quality Improvement
Quality of Life
Radiation Oncology
Radiation Physics
Radiation Therapy
Radiologic Sciences
Radiologic Technology
Radiology
Rare Disorders
Reproductive Health
Rescue Work
Respiratory Care
Respiratory Diseases
Restless Legs Syndrome
Resuscitation
Rheumatic and Immunologic Diseases
Rhinology
Rosacea
Rural Health
Schizophrenia
Scholarships
School Health
Science Education
Scientific Importance/Achievement
Scientific Publication
Scleroderma
Scoliosis
Seed Money/Seed Grant
Sexually Transmitted Diseases
Simulation in Medicine
Skin Cancer
Sleep
Social Work in Medicine
Sonography
Spina Bifida
Spinal Cord
Spinal Muscular Atrophy
Spine
Sports Medicine
Staff Development
Stem Cells
Stroke
Substance Abuse
Sudden Infant Death Syndrome
Suicide
Surgery
Survivorship
Systems Biology
Thromboembolism
Thrombosis
Tinnitus
Tobacco Control
Toxicology
Translational Research
Transplantation
Trauma
Travel Grants
Tuberculosis
Tumors
Ultrasound
Underserved Populations
Urogynecology
Urology
Vascular Disease
Vascular Surgery
Venous Disease
Veterinary Medicine
Violence Prevention
Virology
Women in Medicine
Women in Science
Women's Health
Wound Care
Youth